InvestorsHub Logo
Followers 6
Posts 106
Boards Moderated 0
Alias Born 04/03/2014

Re: None

Thursday, 12/10/2015 5:58:44 PM

Thursday, December 10, 2015 5:58:44 PM

Post# of 400400
They are just breaking ground on the generics side of the business. Unlike most r&d's they do not need a buyout to keep going. I like the setup they have with Epic and I do not see any reason why they cannot partner up for each Art through various pharmas. Eli 200 is a starting point to either partner up, merge, or expand their current operations for the rest of the pipeline. dd glta
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News